Bayesian latent time joint mixed effect models for multicohort longitudinal data

Statistical Methods in Medical Research
Dan LiAlzheimer’s Disease Neuroimaging Initiative


Characterization of long-term disease dynamics, from disease-free to end-stage, is integral to understanding the course of neurodegenerative diseases such as Parkinson's and Alzheimer's, and ultimately, how best to intervene. Natural history studies typically recruit multiple cohorts at different stages of disease and follow them longitudinally for a relatively short period of time. We propose a latent time joint mixed effects model to characterize long-term disease dynamics using this short-term data. Markov chain Monte Carlo methods are proposed for estimation, model selection, and inference. We apply the model to detailed simulation studies and data from the Alzheimer's Disease Neuroimaging Initiative.


Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Jul 5, 2011·The American Journal of Psychiatry·Wesley K ThompsonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 21, 2011·Progress in Neurobiology·UNKNOWN Parkinson Progression Marker Initiative
Mar 25, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael C DonohueUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯


Jun 28, 2019·Journal of Animal Breeding and Genetics = Zeitschrift Für Tierzüchtung Und Züchtungsbiologie·Arthur R Gilmour
Dec 4, 2019·ELife·Sara GarbarinoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 13, 2019·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Murat Bilgel, Bruno M Jedynak
Jun 15, 2020·Alzheimer's Research & Therapy·Christoforos HadjichrysanthouUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 30, 2019·Brain Informatics·Samuel IddiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Oct 20, 2020·NeuroImage·Mostafa Mehdipour GhaziLauge Sørensen
Feb 6, 2021·Brain : a Journal of Neurology·Neil P OxtobyRimona S Weil
Jan 30, 2020·Computer Methods and Programs in Biomedicine·Gerard Martí-JuanGemma Piella
Apr 15, 2021·Statistics in Medicine·Line KühnelLars L Raket
Jun 5, 2021·Brain Communications·Clément Abi NaderUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 17, 2021·Brain Communications·Julie UchitelMohamad A Mikati
Sep 29, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Line KühnelUNKNOWN MEMENTO study group and the Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Software Mentioned

R package rstan ( Stan Development Team
R package

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.